InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-52.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by ARCH Venture Partners IX, LLC. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. In total, 30 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10.8m. History available since 22 June 2021. The latest transaction was filed on 6 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to ARCH Venture Partners IX, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
488,090 shares@ US$25.61100.0% of flowCommon StockSEC:0001012975-26-000235:0
Canonical exit: 4 Jun 2026 (T+90)
196,003 shares0Common StockSEC:0001062993-22-019342:0
217,781 shares0Common StockSEC:0001062993-22-018984:0
217,781 shares0Common StockSEC:0001062993-22-018811:0
217,781 shares0Common StockSEC:0001062993-22-018573:0
282,219 shares0Common StockSEC:0001062993-22-018154:1
13,076 shares0Common StockSEC:0001062993-22-018154:2
1,475 shares0Common StockSEC:0001062993-22-018154:3
2,952 shares0Common StockSEC:0001062993-22-018154:4
217,781 shares0Common StockSEC:0001062993-22-018154:5
282,219 shares0Common StockSEC:0001062993-22-018154:6
13,076 shares0Common StockSEC:0001062993-22-018154:7
1,475 shares0Common StockSEC:0001062993-22-018154:8
2,952 shares0Common StockSEC:0001062993-22-018154:9
217,781 shares0Common StockSEC:0001062993-22-018154:10
282,219 shares0Common StockSEC:0001062993-22-018154:11
13,076 shares0Common StockSEC:0001062993-22-018154:12
1,475 shares0Common StockSEC:0001062993-22-018154:13
2,952 shares0Common StockSEC:0001062993-22-018154:14
217,781 shares0Common StockSEC:0001062993-22-018154:0
217,781 shares0Common StockSEC:0001062993-22-014696:0
217,781 shares0Common StockSEC:0001062993-22-014426:0
762,233 shares0Common StockSEC:0001062993-21-013385:0
217,781 shares0Common StockSEC:0001062993-21-011917:0
217,781 shares0Common StockSEC:0001062993-21-011643:0
25 of 30 declarations
About ARCH Venture Partners IX, LLC
ARCH Venture Partners IX, LLC is a declarant linked to Vir Biotechnology, Inc., Lyell Immunopharma, Inc. and Beam Therapeutics Inc. It has 30 filings in total, and across the sampled recent filings from 2021-06-23 to 2026-03-09, buys total 10768362 EUR and sells 0 EUR, with a transaction nature of J.
